Study protocol, randomized controlled trial: reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and/or D-ribose.

BMC Cardiovasc Disord · 2018 · PMC5879598 · PMID 29606104

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

borderline significantp = 0.08so close (0.05 < p ≤ 0.1)

The 13.7-point increase produced by the independent effect of D-ribose was borderline significant ( t = 2.06, df = 9, two-tailed independent samples p = 0.08).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.